Northwire Canada EditionThursday, July 16, 2026
Northwire
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%

← Back to our analysis

Original News Release

Bausch + Lomb to release 2025 results Feb. 18

Mr. Chris Clark reports BAUSCH + LOMB WILL RELEASE FOURTH-QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS ON FEB. 18 Bausch + Lomb Corp. will release its fourth quarter and full-year 2025 financial results on Wednesday, Feb. 18, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Bausch + Lomb website prior to the start of the call. Conference call details Date:  Wednesday, Feb. 18, 2026 Time:  8 a.m. ET A webcast will be available. Participant event dial-in:  1-888-506-0062 (North America) or 1-973-528-0011 (international) Participant access code:  923960 Replay dial-in:  1-877-481-4010 (North America) or 1-919-882-2331 (international) Replay passcode:  53392 (replay available until March 4, 2026) About Bausch + Lomb Corp. Its mission is simple: The company helps people see better to live better all over the world. For nearly two centuries, it has evolved with the changing needs of patients and customers, and its commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, it is turning bold ideas into better outcomes through passion, perseverance and purpose.
View at source ↗